Skip to main content
. 2021 Jul;93:103113. doi: 10.1016/j.drugpo.2021.103113

Fig. 3.

Fig 3

Cost Effectiveness Acceptability Curves.

A. Control v EBI (societal perspective)

B. Control v PFBA (societal perspective)

C. Control V EBI (NHS/PSS perspective)

D. Control v PFBA (NHS/PSS perspective)